Vaxxinova Revenue and Competitors

Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases. We create high quality solutions to improve animal health and to support our customers. We believe that innovation and excellence in research are essential to produce premium products that match the current and future requirements in animal health. That is why Vaxxinova invests strongly in R&D. Locations Our current network comprises production, research & development, sales and diagnostic facilities in 10 countries: Brazil, Chile, Germany, Italy, Japan, Jordan, Norway, the Netherlands, Thailand and the USA. Vaxxinova is active in more than 60 countries. Job opportunities We are currently expanding our organization, both locally and at the head office. We are looking for new talents and professionals who feel at home in a driven, entrepreneurial and down to earth working environment. Vaxxinova offers their employees excellent opportunities for further professional development. Background Vaxxinova is part of the family-owned EW Group, a German based company specialized in animal genetics, nutrition and animal health. The EW Group is highly committed to R&D, operates in more than 100 countries and records consistent international growth.